Grant: Banting Postdoctoral Fellowship Program
McGill University
$140,000.00
Characterization of tumour-specific epigenetic changes in giant cell tumour of the bone and high-grade pediatric brain cancers
FY 2015-16
Summary
Approximately, 200 Canadian children who are diagnosed with glioblastoma, a type of brain cancer, will ultimately die of their disease. If these kids are given standard treatment they will only survive 12-14 months, therefore new treatment options are urgently needed. A rare bone cancer, called giant cell tumours of the bone are often benign, however can be aggressive tumours resulting in lung metastasis. In these two different tumour types, the same histone 3 genes are mutated. This occurs in 40% of childhood brain cancers and in over 90% of giant cell tumours of the bone. Histones are guardians of the genome, as they are proteins that package DNA, enabling it to be folded tightly together into the nucleus.
The mutations identified in the gene histone 3, affect the epigenetics, (epi- over or outside of) of the cell. This implies altering how genes are expressed without changing the DNA sequence. To also determine how the mutations identified in these two different tumour types affect the epigenetics of the cell, we will use a new technique called Hi-C to determine the 3D structure of DNA. This analysis will give us insight into how the same mutations in different tumour types may change the structure and organization of the nucleus, giving us clues into how the cells become cancerous. This important research will provide new information on the biology of these deadly brain tumours, and rare bone tumours and also lead to new targets for novel therapeutics. Our research will not only help Canadian children, but will positively affect children with brain cancer from all over the world. The ultimate goal of this project is to find a way to provide better treatment options for both rare tumour types, which will provide some hope for surviving these dreadful cancers.
Department
Program
Banting Postdoctoral Fellowship Program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
335317
Name
McConechy Melissa K
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Characterization of tumour-specific epigenetic changes in giant cell tumour of the bone and high-grade pediatric brain cancers
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
3d Chromatin Structure; Chipseq; Epigenetics; Gene Expression; Giant Cell Tumours Of The Bone; H3f3a; Hi-C; Histones; Methylation; Pediatric Brain Cancer
Abstract
Approximately, 200 Canadian children who are diagnosed with glioblastoma, a type of brain cancer, will ultimately die of their disease. If these kids are given standard treatment they will only survive 12-14 months, therefore new treatment options are urgently needed. A rare bone cancer, called giant cell tumours of the bone are often benign, however can be aggressive tumours resulting in lung metastasis. In these two different tumour types, the same histone 3 genes are mutated. This occurs in 40% of childhood brain cancers and in over 90% of giant cell tumours of the bone. Histones are guardians of the genome, as they are proteins that package DNA, enabling it to be folded tightly together into the nucleus.
The mutations identified in the gene histone 3, affect the epigenetics, (epi- over or outside of) of the cell. This implies altering how genes are expressed without changing the DNA sequence. To also determine how the mutations identified in these two different tumour types affect the epigenetics of the cell, we will use a new technique called Hi-C to determine the 3D structure of DNA. This analysis will give us insight into how the same mutations in different tumour types may change the structure and organization of the nucleus, giving us clues into how the cells become cancerous. This important research will provide new information on the biology of these deadly brain tumours, and rare bone tumours and also lead to new targets for novel therapeutics. Our research will not only help Canadian children, but will positively affect children with brain cancer from all over the world. The ultimate goal of this project is to find a way to provide better treatment options for both rare tumour types, which will provide some hope for surviving these dreadful cancers.
Competitiondate
201509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
McConechy, Melissa K
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~